Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04588662




Registration number
NCT04588662
Ethics application status
Date submitted
16/07/2020
Date registered
19/10/2020

Titles & IDs
Public title
A Prospective Natural History Study in Uveal Melanoma
Scientific title
A Prospective Natural History Study in Uveal Melanoma
Secondary ID [1] 0 0
AAAR5976
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Uveal Melanoma 0 0
Condition category
Condition code
Cancer 0 0 0 0
Malignant melanoma
Cancer 0 0 0 0
Other cancer types
Eye 0 0 0 0
Diseases / disorders of the eye

Intervention/exposure
Study type
Observational [Patient Registry]
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Uveal Melanoma - Diagnosis of uveal melanoma Ability to provide written informed consent for participation in the prospective registry OR an institutional waiver by the IRB/ethics committee for retrospective data collection without written informed consent
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Relapse-free Survival Rate
Timepoint [1] 0 0
Up to Five years
Primary outcome [2] 0 0
Overall Survival Rate
Timepoint [2] 0 0
Up to Five years
Primary outcome [3] 0 0
Overall Survival Rate of Patients with Uveal Melanoma
Timepoint [3] 0 0
Up to Five years

Eligibility
Key inclusion criteria
Inclusion Criteria

* Diagnosis of uveal melanoma
* Ability to provide written informed consent for participation in the prospective registry OR an institutional waiver by the IRB/ethics committee for retrospective data collection without written informed consent
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Exclusion Criteria

*None

Study design
Purpose
Duration
Selection
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
6/05/2021
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
1/07/2026
Actual
Sample size
Target
700
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Royal Adelaide Hospital - Adelaide
Recruitment hospital [2] 0 0
Chatswood Eye Specialists - Chatswood
Recruitment hospital [3] 0 0
Royal Victorian Eve and Ear Hospital - East Melbourne
Recruitment hospital [4] 0 0
Western Eye Specialists - Maribyrnong
Recruitment hospital [5] 0 0
Pennington Eye Clinic - North Adelaide
Recruitment hospital [6] 0 0
Perth Retina - Subiaco
Recruitment hospital [7] 0 0
Dr. Conway Private Rooms - Sydney
Recruitment hospital [8] 0 0
St. Vincent's Hospital - Sydney
Recruitment postcode(s) [1] 0 0
- Adelaide
Recruitment postcode(s) [2] 0 0
- Chatswood
Recruitment postcode(s) [3] 0 0
- East Melbourne
Recruitment postcode(s) [4] 0 0
- Maribyrnong
Recruitment postcode(s) [5] 0 0
- North Adelaide
Recruitment postcode(s) [6] 0 0
- Subiaco
Recruitment postcode(s) [7] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Massachusetts
Country [2] 0 0
United States of America
State/province [2] 0 0
New York
Country [3] 0 0
United States of America
State/province [3] 0 0
Pennsylvania
Country [4] 0 0
United States of America
State/province [4] 0 0
Texas
Country [5] 0 0
Canada
State/province [5] 0 0
Toronto
Country [6] 0 0
Germany
State/province [6] 0 0
Erlangen
Country [7] 0 0
United Kingdom
State/province [7] 0 0
Birkenhead
Country [8] 0 0
United Kingdom
State/province [8] 0 0
Northwood
Country [9] 0 0
United Kingdom
State/province [9] 0 0
Sheffield

Funding & Sponsors
Primary sponsor type
Other
Name
Columbia University
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Shaheer Khan, DO
Address 0 0
Columbia University
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Research Nurse Navigator
Address 0 0
Country 0 0
Phone 0 0
212-342-5162
Fax 0 0
Email 0 0
cancerclinicaltrials@cumc.columbia.edu
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Undecided
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT04588662